Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Antibe Therapeutics Total Liabilities (Quarterly): 22.93M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.93M |
| September 30, 2023 | 22.44M |
| June 30, 2023 | 24.18M |
| March 31, 2023 | 22.47M |
| December 31, 2022 | 22.45M |
| September 30, 2022 | 23.69M |
| June 30, 2022 | 24.40M |
| March 31, 2022 | 25.89M |
| December 31, 2021 | 24.50M |
| September 30, 2021 | 24.47M |
| June 30, 2021 | 25.10M |
| March 31, 2021 | 24.94M |
| December 31, 2020 | 5.966M |
| September 30, 2020 | 5.292M |
| June 30, 2020 | 5.895M |
| March 31, 2020 | 7.093M |
| December 31, 2019 | 6.341M |
| September 30, 2019 | 6.303M |
| June 30, 2019 | 5.715M |
| March 31, 2019 | 5.526M |
| December 31, 2018 | 4.821M |
| September 30, 2018 | 4.466M |
| Date | Value |
|---|---|
| June 30, 2018 | 3.881M |
| March 31, 2018 | 3.497M |
| December 31, 2017 | 5.619M |
| September 30, 2017 | 5.800M |
| June 30, 2017 | 5.702M |
| March 31, 2017 | 5.378M |
| December 31, 2016 | 4.366M |
| September 30, 2016 | 4.302M |
| June 30, 2016 | 4.218M |
| March 31, 2016 | 3.877M |
| December 31, 2015 | 3.346M |
| September 30, 2015 | 0.2893M |
| June 30, 2015 | 0.3147M |
| March 31, 2015 | 0.3566M |
| December 31, 2014 | 0.2562M |
| September 30, 2014 | 0.5931M |
| June 30, 2014 | 0.4733M |
| March 31, 2014 | 0.9344M |
| December 31, 2013 | 0.8817M |
| September 30, 2013 | 0.6299M |
| June 30, 2013 | 1.001M |
| March 31, 2013 | 1.717M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.292M
Minimum
Sep 2020
25.89M
Maximum
Mar 2022
17.37M
Average
22.47M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| InMed Pharmaceuticals Inc | 2.254M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.49M |
| Shareholders Equity (Quarterly) | 19.55M |